{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T15:04:27Z","timestamp":1788447867144,"version":"build-2803163510"},"reference-count":24,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2021,4,17]],"date-time":"2021-04-17T00:00:00Z","timestamp":1618617600000},"content-version":"vor","delay-in-days":16,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Candida empyema thoracis (pleural empyema) is an uncommon manifestation of invasive candidiasis, for which optimal treatment is unknown.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This is a retrospective study of patients with Candida empyema at 2 academic medical centers from September 2006 through December 2015.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>We identified 81 patients with Candida empyema (median age, 62 years; 68% men). Sixty-five percent of patients underwent surgery or an invasive intervention of the thorax or abdomen within the preceding 90 days. Candida empyema originated from intrathoracic (51%) or intra-abdominal sources (20%), spontaneous esophageal rupture (12%), pleural space manipulation (9%), and pneumonia (6%). Eighty-four percent and 41% of patients were intensive care unit residents and in septic shock, respectively, within 3 days of diagnosis. Causative species were Candida albicans (65%), Candida glabrata (26%), Candida parapsilosis (11%), Candida tropicalis (4%), Candida krusei (2%), and Candida dubliniensis (1%). Bacteria were recovered from empyemas in 51% of patients. Concurrent candidemia was diagnosed in only 2% of patients. Management included pleural drainage and antifungal treatment in 98% and 85% of patients, respectively. Mortality at 100 days was 27%, and it was highest for cases stemming from esophageal rupture (67%). Spontaneous esophageal rupture and echinocandin rather than fluconazole treatment were independent risk factors for death at 100 days (P = .003 and .04, respectively); receipt of antifungal therapy was an independent predictor of survival (P = .046).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Candida empyema mortality rates were lower than reported previously. Optimal management included pleural drainage and fluconazole treatment. Superiority of fluconazole over echinocandins against Candida empyema needs to be confirmed in future studies.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ofid\/ofaa656","type":"journal-article","created":{"date-parts":[[2021,4,17]],"date-time":"2021-04-17T11:59:33Z","timestamp":1618660773000},"source":"Crossref","is-referenced-by-count":32,"title":["<i>Candida<\/i> Empyema Thoracis at Two Academic Medical Centers: New Insights Into Treatment and Outcomes"],"prefix":"10.1093","volume":"8","author":[{"given":"Suheyla S","family":"Senger","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases and Clinical Microbiology, University of Health Sciences Turkey, Tepecik Training and Research Hospital, Izmir, Turkey"},{"name":"Division of Infectious Diseases, Department of Internal Medicine University of California Davis Medical Center, Sacramento, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"George R","family":"Thompson","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Internal Medicine University of California Davis Medical Center, Sacramento, California, USA"},{"name":"Department of Medical Microbiology and Immunology, University of California Davis Medical Center, Sacramento, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Palash","family":"Samanta","sequence":"additional","affiliation":[{"name":"University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jillian","family":"Ahrens","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Internal Medicine University of California Davis Medical Center, Sacramento, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelius J","family":"Clancy","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA"},{"name":"VA Pittsburgh Healthcare System, Pittsburgh, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M Hong","family":"Nguyen","sequence":"additional","affiliation":[{"name":"University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA"},{"name":"Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,4,17]]},"reference":[{"key":"2021070723374415200_CIT0001","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jmii.2012.08.010","article-title":"Report of a 63-case series of Candida empyema thoracis: 9-year experience of two medical centers in central Taiwan","volume":"47","author":"Lin","year":"2014","journal-title":"J Microbiol Immunol Infect"},{"key":"2021070723374415200_CIT0002","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.jinf.2016.02.014","article-title":"Fungal empyema thoracis in cancer patients","volume":"72","author":"Nigo","year":"2016","journal-title":"J Infect"},{"key":"2021070723374415200_CIT0003","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1378\/chest.117.6.1672","article-title":"Fungal empyema thoracis: an emerging clinical entity","volume":"117","author":"Ko","year":"2000","journal-title":"Chest"},{"key":"2021070723374415200_CIT0004","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/civ933","article-title":"Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2021070723374415200_CIT0005","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1128\/AAC.01560-10","article-title":"Pharmacokinetics of anidulafungin in pleural fluid during the treatment of a patient with Candida empyema","volume":"55","author":"Moriyama","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"2021070723374415200_CIT0006","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s10156-011-0240-3","article-title":"Distribution of micafungin in the tissue fluids of patients with invasive fungal infections","volume":"17","author":"Yamada","year":"2011","journal-title":"J Infect Chemother"},{"key":"2021070723374415200_CIT0007","doi-asserted-by":"crossref","first-page":"e02326","DOI":"10.1128\/AAC.02326-17","article-title":"Anidulafungin pharmacokinetics in ascites fluid and pleural effusion of critically ill patients","volume":"62","author":"Welte","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"2021070723374415200_CIT0008","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/cid\/ciz156","article-title":"Invasive fungal infection after lung transplantation: epidemiology in the setting of antifungal prophylaxis","volume":"70","author":"Baker","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2021070723374415200_CIT0009","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/clinids\/22.5.747","article-title":"Pleural empyema","volume":"22","author":"Bryant","year":"1996","journal-title":"Clin Infect Dis"},{"key":"2021070723374415200_CIT0010","first-page":"506","article-title":"Demonstration of a local exhaustion of complement components and of an enzymatic degradation of immunoglobulins in pleural empyema: a possible factor favouring the persistence of local bacterial infections","volume":"42","author":"Lew","year":"1980","journal-title":"Clin Exp Immunol"},{"key":"2021070723374415200_CIT0011","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00004836-200301000-00020","article-title":"Low complement levels and opsonic activity in hepatic hydrothorax: its relationship with spontaneous bacterial empyema","volume":"36","author":"Sese","year":"2003","journal-title":"J Clin Gastroenterol"},{"key":"2021070723374415200_CIT0012","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1378\/chest.102.5.1316","article-title":"Management of acute empyema","volume":"102","author":"Moores","year":"1992","journal-title":"Chest"},{"key":"2021070723374415200_CIT0013","article-title":"Candida infections of the abdomen and thorax","author":"Kauffman"},{"key":"2021070723374415200_CIT0014","doi-asserted-by":"crossref","first-page":"e0153247","DOI":"10.1371\/journal.pone.0153247","article-title":"Intra-abdominal candidiasis: the importance of early source control and antifungal treatment","volume":"11","author":"Vergidis","year":"2016","journal-title":"PLoS One"},{"key":"2021070723374415200_CIT0015","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.2169\/internalmedicine.49.2860","article-title":"A case of Aspergillus empyema successfully treated with combination therapy of voriconazole and micafungin: excellent penetration of voriconazole and micafungin into pleural fluid","volume":"49","author":"Matsuda","year":"2010","journal-title":"Intern Med"},{"key":"2021070723374415200_CIT0016","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1128\/CMR.00046-13","article-title":"Tissue penetration of antifungal agents","volume":"27","author":"Felton","year":"2014","journal-title":"Clin Microbiol Rev"},{"key":"2021070723374415200_CIT0017","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/BF02113615","article-title":"Fluconazole concentrations in pulmonary tissue and pericardial fluid","volume":"25","author":"Rieder-Nelissen","year":"1997","journal-title":"Infection"},{"key":"2021070723374415200_CIT0018","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1128\/AAC.48.3.1065.2004","article-title":"Pleural diffusion of voriconazole in a patient with Aspergillus fumigatus empyema thoracis","volume":"48","author":"Stern","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"2021070723374415200_CIT0019","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1007\/s00134-006-0113-x","article-title":"Pericardial and pleural diffusion of voriconazole during disseminated invasive aspergillosis: report of a case with successful outcome","volume":"32","author":"Poupelin","year":"2006","journal-title":"Intensive Care Med"},{"key":"2021070723374415200_CIT0020","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1378\/chest.117.6.1734","article-title":"Antibiotic levels in empyemic pleural fluid","volume":"117","author":"Teixeira","year":"2000","journal-title":"Chest"},{"key":"2021070723374415200_CIT0021","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1177\/1457496916654097","article-title":"Predictors of morbidity and mortality in esophageal perforation: retrospective study of 80 patients","volume":"106","author":"Zimmermann","year":"2017","journal-title":"Scand J Surg"},{"key":"2021070723374415200_CIT0022","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0002-9343(95)00010-0","article-title":"The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance","volume":"100","author":"Nguyen","year":"1996","journal-title":"Am J Med"},{"key":"2021070723374415200_CIT0023","first-page":"e00111","article-title":"Candida","volume":"32","author":"Toth","year":"2019","journal-title":"Clin Microbiol Rev"},{"key":"2021070723374415200_CIT0024","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1093\/cid\/cit006","article-title":"Finding the \u201cMissing 50%\u201d of invasive candidiasis: how nonculture diagnostics will improve understanding of disease spectrum and transform patient care","volume":"56","author":"Clancy","year":"2013","journal-title":"Clin Infect Dis"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ofid\/article-pdf\/8\/4\/ofaa656\/37114080\/ofaa656.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ofid\/article-pdf\/8\/4\/ofaa656\/37114080\/ofaa656.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,8]],"date-time":"2021-07-08T02:14:18Z","timestamp":1625710458000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofaa656\/6231796"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,1]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofaa656","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,4,1]]},"published":{"date-parts":[[2021,4,1]]},"article-number":"ofaa656"}}